Sulica L, Rosen CA, Postma GN, et al. Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications

Department of Otorhinolaryngology, Weill Cornell Medical College, New York, New York 10021, USA.
The Laryngoscope (Impact Factor: 2.14). 11/2009; 120(2):319-25. DOI: 10.1002/lary.20737
Source: PubMed


To identify contemporary indications, treatment principles, technique, injection materials, complications, and success rates of vocal fold injection augmentation.
Multi-institutional retrospective review.
Records of patients undergoing injection augmentation at seven university medical centers from July 2007 through June 2008 were reviewed for information regarding diagnosis, unilateral or bilateral injection, route of injection, anesthesia, treatment site (office or operating room), material used, reason for technique selected, and technical success.
In 12 months, 460 injections were performed, 236 (51%) in awake, unsedated patients, and 224 (49%) under general anesthesia. Indications included vocal fold paralysis (248; 54%), paresis (97; 21%), atrophy (68; 15%) and scar (47; 10%). Scar was more likely to be treated in the operating room (P = .000052). In awake patients, 112 (47%) injections were performed by transcricothyroid approach, 55 (23%) by peroral approach, 49 (21%) by transthyrohyoid membrane approach, and 20 (8%) by transthyroid cartilage approach. Neither technical success rate (99% vs. 97%) nor complication rate (3% vs. 2%) differed between awake and asleep techniques. The most common materials in the clinic setting were methylcellulose (35%), bovine collagen (28%), and calcium hydroxylapatite (26%); in the operating room these were calcium hydroxylapatite (36%) and methylcellulose (35%). Calcium hydroxylapatite was more likely to be used under general anesthesia (P = .019). Five-year data show that the use of injection in the awake patient rose from 11% to 43% from 2003 to 2008.
Injection augmentation remains a safe, effective, and clinically practical treatment with a high rate of success, whether performed in the awake or asleep patient. The rapid adoption of awake injection over the past 5 years speaks to its clinical utility. Complication rates are low and equivalent to those under general anesthesia. Otolaryngologists continue to use a variety of techniques and materials to treat a range of conditions of glottic insufficiency.

1 Follower
23 Reads
  • Source
    • "Over the past 10 years, advances in materials science have led to the development of a number of injectables with excellent safety and biomechanical profiles, making it possible to avoid deleterious foreign body and inflammatory reactions caused by paraffin, silicone, and Teflon™.4,5 Popular materials for injection laryngoplasty include hyaluronic acid and artificial bovine collagen. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose To overcome the potential disadvantages of the use of foreign materials and autologous fat or collagen, we introduce here an autologous plasma gel for injection laryngoplasty. The purpose of this study was to present a new injection material, a plasma gel, and to discuss its clinical effectiveness. Materials and Methods From 2 mL of blood, the platelet poor serum layer was collected and heated at 100℃ for 12 min to form a plasma gel. The plasma gel was then injected into a targeted site; the safety and efficacy thereof were evaluated in 30 rats. We also conducted a phase I/II clinical study of plasma gel injection laryngoplasty in 11 unilateral vocal fold paralysis patients. Results The plasma gel was semi-solid and an easily injectable material. Of note, plasma gel maintains the same consistency for up to 1 year in a sealed bottle. However, exposure to room air causes the plasma gel to disappear within 1 month. In our animal study, the autologous plasma gel remained in situ for 6 months in animals with minimal inflammation. Clinical study showed that vocal cord palsy was well compensated for with the plasma gel in all patients at two months after injection with no significant complications. Jitter, shimmer, maximum, maximum phonation time (MPT) and mean voice handicap index (VHI) also improved significantly after plasma gel injection. However, because the injected plasma gel was gradually absorbed, 6 patients needed another injection, while the gel remained in place in 2 patients. Conclusion Injection laryngoplasty with autologous plasma gel may be a useful and safe treatment option for temporary vocal cord palsy.
    Yonsei medical journal 11/2013; 54(6):1516-23. DOI:10.3349/ymj.2013.54.6.1516 · 1.29 Impact Factor
  • Source
    • "Over injection can even lead to dyspnea and stridor. Abscess formation often infiltrating subglottically or extralaryngeally has also been reported [200]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: More than half of patients who present with the symptom of hoarseness show benign vocal fold changes. The clinician should be familiar with modern diagnostic and therapeutic possibilities of benign vocal fold changes in order to ensure an optimal and individualized attention to voice patients. Basic knowledge of the etiology are provided for targeted phonosurgical or conservative therapy. This review article focuses on the diagnostic and therapeutic limitations and difficulties of treatment of benign vocal fold tumors, the management and prophylaxis of scarred vocal fold changes and the issue of unilateral vocal fold paralysis.
    Laryngo-Rhino-Otologie 04/2013; 92 Suppl 1:S239-57. DOI:10.1055/s-0032-1333304 · 0.84 Impact Factor
  • Source
    • "Though VFI in the awake patient was initially described over a century ago, VFI in an in-office setting has re-emerged in the past decade as an attractive alternative to microsuspension laryngoscopy. Pointing to the popularity of this technique, a recent multi-institutional review revealed that VFI was performed equally often in an awake patient as one under general anesthesia (3). VFI in the awake setting has the distinct advantages of providing direct feedback of vocal fold closure and voice outcome during the injection, avoiding limitations of difficult exposure, and avoiding general anesthesia with its inherent risks and increased cost (4). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vocal fold injection is a procedure that has over a 100 year history but was rarely done as short as 20 years ago. A renaissance has occurred with respect to vocal fold injection due to new technologies (visualization and materials) and new injection approaches. Awake, un-sedated vocal fold injection offers many distinct advantages for the treatment of glottal insufficiency (vocal fold paralysis, vocal fold paresis, vocal fold atrophy and vocal fold scar). A review of materials available and different vocal fold injection approaches is performed. A comparison of vocal fold injection to laryngeal framework surgery is also undertaken. With proper patient and material selection, vocal fold injection now plays a major role in the treatment of many patients with dysphonia.
    Clinical and Experimental Otorhinolaryngology 12/2010; 3(4):177-82. DOI:10.3342/ceo.2010.3.4.177 · 0.85 Impact Factor
Show more